To boost support for caregivers on an international scale, Merck KGaA of Darmstadt, Germany, launched a worldwide program called Embracing Carers and presented recent survey results at a conference in Australia.
A clinical trial for potential Ebola vaccines demonstrated an immune response lasting up to one year and what scientists consider salient data, according to results recently published in the New England Journal of Medicine.
Lacking social perspective and coping with processing differences is not typical of most employees, but for those with Asperger’s syndrome (AS) or other autism spectrum disorder (ASD), these challenges are more common than most people realize.
Eli Lilly recently dispatched commercial medical supplies, including insulin, to the storm-ravaged island of Puerto Rico for humanitarian distribution following severe hurricane damage to much of the territory’s infrastructure.
The question of whether a specific vitamin regimen can be trademarked was settled recently when Eli Lilly successfully retained its right to patent an injectable non-small cell lung cancer treatment called Alimta (pemetrexed).
Gene expression recently caught the attention of neuroscientists at the University of Pennsylvania’s Perelman School of Medicine, who subsequently undertook a study to see whether prenatal brain development can impact mental illness later in life.
When statistics don’t appear to synchronize with consumer experience, it may be time to look more closely at direct influences behind medicine expenses, a Pharmaceutical Research and Manufacturers of America (PhRMA) expert suggested recently.
Bristol-Myers Squibb said its Opdivo (nivolumab) treatment recently became the first to obtain U.S. Food and Drug Administration (FDA) approval for certain types of cancer patients whose illness proved unresponsive to prior regimens.
A partnership among three government agencies has resulted in a multimodal approach to treating chronic pain in U.S. military members, thanks to funding from the National Institutes of Health's (NIH) National Center for Complementary and Integrative Health.
Clarifying recent modifications to the nation’s health care policies, American Medical Association (AMA) President David Barbe recently made several recommendations for practitioners to improve efficiency in a posting on the AMA website.
Medicine doesn’t operate effectively in a vacuum; rather, health care is most successful when done collaboratively, East Carolina University’s Brody School of Medicine faculty said during a presentation at a recent American Medical Association conference.
The Centers for Medicare and Medicaid Services (CMS) recently said health care plan organizations are not permitted to mandate that medical practices honor credit operations known for tacking on overpriced service charges.
National Institutes of Health (NIH) and Sanofi researchers recently found that a laboratory-generated, three-pronged antibody protects monkeys from HIV-type infection better than the natural antibodies it's based on, according to an announcement.
Merck KGaA and Pfizer Inc. recently obtained approval of Bavencio (avelumab) as Japan’s first treatment for Merkel cell carcinoma (MCC), citing endorsement from the Japanese Ministry of Health, Labor and Welfare (MHLW).
Sucampo Pharmaceuticals Inc. recently attained Food and Drug Administration (FDA) acceptance of its supplemental new drug application (sNDA) for Amitiza (lubiprostone), a product designed to address pediatric functional constipation.
Research on home-based phototherapy treatment for psoriasis proposed by Dr. Joel Gelfand of the University of Pennsylvania's medical school recently obtained $8.6 million in funding from the Patient-Centered Outcomes Research Institute (PCORI).
Though statistics indicate more severe eczema cases in black children nationwide, these youngsters make fewer trips to a doctor’s office for the condition than other children, a University of Pennsylvania has found.
Dupixent (dupilumab), a medication jointly marketed by Sanofi and Regeneron Pharmaceuticals for relieving a form of eczema known as atopic dermatitis (AD) in adults, recently received marketing approval in the European Union (EU).
Wearable apps or devices may prove instrumental to improving exercise levels, according to a joint study by University of Pennsylvania and Boston University medical schools that also suggested family participation can help to increase physical activity.